Cross-Resistance among Nonnucleoside Reverse Transcriptase Inhibitors Limits Recycling Efavirenz after Nevirapine Failure-Reference-Cited by-同舟云学术

Cross-Resistance among Nonnucleoside Reverse Transcriptase Inhibitors Limits Recycling Efavirenz after Nevirapine Failure

Published:2002-08-20 Issue:12 Volume:18 Page:835-838
ISSN:0889-2229
Container-title:AIDS Research and Human Retroviruses
language:en
Short-container-title:AIDS Research and Human Retroviruses

Author:

Antinori Andrea¹,Zaccarelli Mauro¹,Cingolani Antonella²,Forbici Federica¹,Rizzo Maria G.²,Trotta Maria P.¹,Di Giambenedetto Simona³,Narciso Pasquale¹,Ammassari Adriana²,Girardi Enrico¹,De Luca Andrea²,Perno Carlo F.¹

Affiliation:

1. National Institute for Infectious Diseases Lazzaro Spallanzani, IRCCS, 00149 Rome, Italy

2. Department of Infectious Diseases, Catholic University, 00168 Rome, Italy

3. Department of Infectious Diseases, Catholic University, 00168 Rome, Italy3

Publisher

Mary Ann Liebert Inc

Subject

Infectious Diseases,Virology,Immunology

Link

http://www.liebertpub.com/doi/pdf/10.1089/08892220260190308

Reference8 articles.

1. Clinical Use of Genotypic and Phenotypic Drug Resistance Testing to Monitor Antiretroviral Chemotherapy

2. Nevirapine resistance mutations of human immunodeficiency virus type 1 selected during therapy

3. Human Immunodeficiency Virus Type 1 Mutations Selected in Patients Failing Efavirenz Combination Therapy

4. Incomplete Genotypic Resistance to Nonnucleoside Reverse Transcriptase Inhibitors in Patients Treated With Nevirapine: A Potential Interest in Clinical Practice

5. Patterns of Resistance Mutations Selected by Treatment of Human Immunodeficiency Virus Type 1 Infection with Zidovudine, Didanosine, and Nevirapine

Cited by 111 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence of human immunodeficiency virus drug resistance and factors associated with high viral load among adolescents on antiretroviral therapy in Dar Es Salaam, Tanzania;HIV Research & Clinical Practice;2024-09-08

2. Archived rilpivirine-associated resistance mutations among ART-naive and virologically suppressed people living with HIV-1 subtype C in Botswana: implications for cabotegravir/rilpivirine use;Journal of Antimicrobial Chemotherapy;2023-08-16

3. HIV and Drug-Resistant Subtypes;Microorganisms;2023-01-15

4. Evaluation of the HIV-1 drug resistance to elsulfavirine and the effectiveness of it among Russian treatment-naïve patients;Journal Infectology;2021-01-21

5. Differential Contribution of HIV-1 Subtypes B and C to Neurological Disorders: Mechanisms and Possible Treatments;Aids Reviews;2019-07-26